Endoscopic technological innovations for neoplasia detection in organized colorectal cancer screening programs: a systematic review and meta-analysis

被引:8
作者
Thayalasekaran, Sreedhari [1 ]
Frazzoni, Leonardo [2 ]
Antonelli, Giulio [3 ]
Fuccio, Lorenzo [2 ]
Radaelli, Franco [4 ]
Andrealli, Alida [4 ]
Senore, Carlo [5 ]
Repici, Alessandro [6 ]
Hassan, Cesare [3 ]
Bhandari, Pradeep [1 ]
机构
[1] Portsmouth Hosp NHS Trust, Dept Gastroenterol, Portsmouth, Hants, England
[2] Univ Bologna, Policlin St Orsola Malpighi, UOC Gastroenterol & Endoscopia Digest, Bologna, Italy
[3] Nuovo Regina Margherita Hosp, Gastroenterol Unit, Via Emilio Morosini 30, I-00153 Rome, Italy
[4] Osped Valduce, Gastroenterol Unit, Como, Italy
[5] Univ Hosp Citta Salute & Sci, Epidemiol & Screening Unit CPO, Turin, Italy
[6] Humanitas Univ, Endoscopy Unit, Rozzano, Italy
关键词
OCCULT BLOOD-TEST; COLONOSCOPY; QUALITY;
D O I
10.1016/j.gie.2020.06.046
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Many endoscopic technological innovations have claimed to increase the adenoma detection rate (ADR), but their role in population-based organized screening programs is debated. Methods: We searched PubMed, EMBASE, and Cochrane Library databases through January 2020 for randomized controlled trials (RCTs) evaluating the role of technological innovations in fecal immunochemical test (FIT)/fecal occult blood test+ subjects. The primary outcome was ADR, and secondary outcomes were advanced ADR, proximal colon ADR, mean adenoma per procedure (MAP), and cancer detection rate. We calculated pooled proportion rates (%) or risk ratio with 95% confidence interval (CI) and degree of heterogeneity (I-2). Results: Overall, 8 high quality RCTs met inclusion criteria with 3645 patients, 1813 (49.7%) in the intervention arm (advanced imaging, 3 studies; mechanical, 5 studies) and 1832 (50.3%) in the standard colonoscopy arm (mean age, 63.6 years). Pooled ADR was 56.5% (95% CI, 49.9%-62.9%) in the intervention arm and 55.9% (95% CI, 48.6%-63%) in the standard colonoscopy arm (relative risk [RR], 1.01; 95% CI, .93-1.10; I-2 = 50.4%). Similarly, no difference was observed for advanced imaging studies (RR, .95; 95% CI, .85-1.07; I-2 = 50.4%) or those with mechanical innovations (RR, 1.04; 95% CI, .92-1.17; I-2 = 69.49%). The pooled MAP was 1.5 in the intervention arm (95% CI, 1.2-1.8) and 1.5 in the standard colonoscopy (95% CI, 1.1-1.8), with no significant difference (unstandardized mean difference, .04; 95% CI, -.13 to .20; I-2 = 53.6%). No difference in advanced ADR, proximal colon ADR, or cancer detection was found. No significant publication bias was found. Conclusions: In our systematic review and meta-analysis, no technological improvement significantly increased detection rate of colorectal neoplasia in FIT+ subjects undergoing high-quality colonoscopy by high detectors, arguing against their implementation in organized programs.
引用
收藏
页码:840 / +
页数:17
相关论文
共 24 条
  • [1] Narrow-Band Imaging for Detection of Neoplasia at Colonoscopy: A Meta-analysis of Data From Individual Patients in Randomized Controlled Trials
    Atkinson, Nathan S. S.
    Ket, Shara
    Bassett, Paul
    Aponte, Diego
    De Aguiar, Silvia
    Gupta, Neil
    Horimatsu, Takahiro
    Ikematsu, Hiroaki
    Inoue, Takuya
    Kaltenbach, Tonya
    Leung, Wai Keung
    Matsuda, Takahisa
    Paggi, Silvia
    Radaelli, Franco
    Rastogi, Amit
    Rex, Douglas K.
    Sabbagh, Luis C.
    Saito, Yutaka
    Sano, Yasushi
    Saracco, Giorgio M.
    Saunders, Brian P.
    Senore, Carlo
    Soetikno, Roy
    Vemulapalli, Krishna C.
    Jairath, Vipul
    East, James E.
    [J]. GASTROENTEROLOGY, 2019, 157 (02) : 462 - 471
  • [2] Endocuff-assisted vs. standard colonoscopy in the fecal occult blood test-based UK Bowel Cancer Screening Programme (E-cap study): a randomized trial
    Bhattacharyya, Rupam
    Chedgy, Fergus
    Kandiah, Kesavan
    Fogg, Carole
    Higgins, Bernard
    Haysom-Newport, Ben
    Gadeke, Lisa
    Thursby-Pelham, Fergus
    Ellis, Richard
    Goggin, Patrick
    Longcroft-Wheaton, Gaius
    Bhandari, Pradeep
    [J]. ENDOSCOPY, 2017, 49 (11) : 1043 - 1050
  • [3] Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs
    Cubiella, Joaquin
    Castells, Antoni
    Andreu, Montserrat
    Bujanda, Luis
    Carballo, Fernando
    Jover, Rodrigo
    Lanas, Angel
    Diego Morillas, Juan
    Salas, Dolores
    Quintero, Enrique
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (02) : 255 - 260
  • [4] Compared Abilities of Endoscopic Techniques to Increase Colon Adenoma Detection Rates: A Network Meta-analysis
    Facciorusso, Antonio
    Triantafyllou, Konstantinos
    Murad, Mohammad Hassan
    Prokop, Larry J.
    Tziatzios, Georgios
    Muscatiello, Nicola
    Singh, Siddharth
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (12) : 2439 - +
  • [5] Diagnostic yield and miss rate of EndoRings in an organized colorectal cancer screening program: the SMART (Study Methodology for ADR- Related Technology) trial
    Hassan, Cesare
    Senore, Carlo
    Manes, Gianpiero
    Fuccio, Lorenzo
    Iacopini, Federico
    Ricciardiello, Luigi
    Anderloni, Andrea
    Frazzoni, Leonardo
    Ballanti, Riccardo
    de Nucci, Germana
    Colussi, Dora
    Redaelli, Davide
    Lorenzetti, Roberto
    Devani, Massimo
    Arena, Ilaria
    Grossi, Cristina
    Andrei, Fabio
    Balestrazzi, Eleonora
    Sharma, Prateek
    Rex, Douglas K.
    Repici, Alessandro
    [J]. GASTROINTESTINAL ENDOSCOPY, 2019, 89 (03) : 583 - +
  • [6] Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme
    Hassan, Cesare
    Senore, Carlo
    Radaelli, Franco
    De Pretis, Giovanni
    Sassatelli, Romano
    Arrigoni, Arrigo
    Manes, Gianpiero
    Amato, Arnaldo
    Anderloni, Andrea
    Armelao, Franco
    Mondardini, Alessandra
    Spada, Cristiano
    Omazzi, Barbara
    Cavina, Maurizio
    Miori, Gianni
    Campanale, Chiara
    Sereni, Giuliana
    Segnan, Nereo
    Repici, Alessandro
    [J]. GUT, 2017, 66 (11) : 1949 - 1955
  • [7] Higgins J.P., 2011, BMJ, V343, pd5928, DOI [DOI 10.1136/BMJ.D5928, 10.1136/bmj.d5928]
  • [8] Leadership training to improve adenoma detection rate in screening colonoscopy: a randomised trial
    Kaminski, Michal F.
    Anderson, John
    Valori, Roland
    Kraszewska, Ewa
    Rupinski, Maciej
    Pachlewski, Jacek
    Wronska, Ewa
    Bretthauer, Michael
    Thomas-Gibson, Siwan
    Kuipers, Ernst J.
    Regula, Jaroslaw
    [J]. GUT, 2016, 65 (04) : 616 - 624
  • [9] Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme
    Lee, Thomas J. W.
    Rutter, Matthew D.
    Blanks, Roger G.
    Moss, Sue M.
    Goddard, Andrew F.
    Chilton, Andrew
    Nickerson, Claire
    McNally, Richard J. Q.
    Patnick, Julietta
    Rees, Colin J.
    [J]. GUT, 2012, 61 (07) : 1050 - 1057
  • [10] Screening for Colorectal Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
    Lin, Jennifer S.
    Piper, Margaret A.
    Perdue, Leslie A.
    Rutter, Carolyn M.
    Webber, Elizabeth M.
    O'Connor, Elizabeth
    Smith, Ning
    Whitlock, Evelyn P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (23): : 2576 - 2594